Logo

Start-up Pharmacogenomics Firm Gentris Locks in $1.5M in Private Equity

Mar 19, 2002

NEW YORK, March 19 - Start-up pharmacogenomics company Gentris on Tuesday said it has secured $1.5 million in private-equity financing.

 

Research Triangle Ventures and Exelixis led the round, which also included angel investors.

 

Gentris said it plans to use the cash to "up-fit" its lab and hire "key senior staff."

 

The company, founded last year, aims to build a "turnkey pharmacogenomic solution of products and services." It is based in Research Triangle Park, NC.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.